On July 23, 2026 Lilly said it plans to submit a Biologics License Application in the first quarter of 2027 superseding its earlier guidance of a 2026 submission
GLP-1 receptor agonist therapy is a long-term commitment, and your strategy needs to account for years of treatment, not just the next few months
Take the next step in your performance journey
E., Spiegelman, D., Barbieri, R
GAPDH was used as an internal control and the expression of osteo/odontoblast-related genes ( DSPP, DMP1, RUNX2, OSX, COL-I and OCN ) was measured by the method of 2 Ct as previously reported 38,56
Minimum purity: 98%, supported by batch-specific analytical documentation where applicable